Cargando…
miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype
In recent years, the assessment of biomarkers useful for “precision medicine” has been a hot topic in research. The involvement of microRNAs in the pathogenesis of breast cancer has been highly investigated with the aim of being able to molecularly stratify this highly heterogeneous disease. Our aim...
Autores principales: | Tommasi, Stefania, Pinto, Rosamaria, Danza, Katia, Pilato, Brunella, Palumbo, Orazio, Micale, Lucia, Summa, Simona De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348325/ https://www.ncbi.nlm.nih.gov/pubmed/27385001 http://dx.doi.org/10.18632/oncotarget.10345 |
Ejemplares similares
-
MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis
por: Danza, Katia, et al.
Publicado: (2014) -
Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients
por: Danza, Katia, et al.
Publicado: (2014) -
TGFbeta and miRNA regulation in familial and sporadic breast cancer
por: Danza, Katia, et al.
Publicado: (2017) -
miRNAs as Key Players in the Management of Cutaneous Melanoma
por: Lorusso, Celeste, et al.
Publicado: (2020) -
Next-generation sequencing: advances and applications in cancer diagnosis
por: Serratì, Simona, et al.
Publicado: (2016)